Perhaps it was not surprising that genetic or HDACi-mediated suppression of EVI1 led to a decrement of MYC in ex vivo EVI1High AML patient blasts and cell lines (Fig. 5F, Supplementary Fig. 7F, G). Here, MECOM is linked to acute myeloid leukemia.